Evidence map›Paper›PMID 37875843›Full record

ArticleBMC surgery2023

Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study.

Chuan-Ming Wang, Zi-Xiang Chen, Ping-Chuan Ma, Jiang-Ming Chen, Dong Jiang, Xin-Yuan Hu, Fu-Xiao Ma, Hui Hou, Jin-Liang Ma, Xiao-Ping Geng and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Chuan-Ming WangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Zi-Xiang ChenDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Ping-Chuan MaDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Jiang-Ming ChenDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Dong JiangDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Xin-Yuan HuDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Fu-Xiao MaDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Hui HouDepartment of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Anhui, 230601, China.
Jin-Liang MaDepartment of General Surgery, The First Affiliated Hospital of University of Science and Technology, Anhui, 230031, China.
Xiao-Ping GengDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China.
Fu-Bao LiuDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui, 230022, China. lfbahmu@outlook.com.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNSecond Hospital of Anhui Medical University · CN

Funding

the University Natural Science Research Project of Anhui Province No. KJ2021ZD0021
6 · The paper itself

Abstract

purposeWith increasing life expectancy, the number of elderly patients (≥ 65 years) with hepatocellular carcinoma (HCC) has steadily increased. Hepatectomy remains the first-line treatment for HCC patients. However, the prognosis of hepatectomy for elderly patients with HCC remains unclear.

methodsClinical and follow-up data from 1331 HCC patients who underwent surgery between 2008 and 2020 were retrospectively retrieved from a multicentre database. Patients were divided into elderly (≥ 65 years) and non-elderly (< 65 years) groups, and PSM was used to balance differences in the baseline characteristics. The postoperative major morbidity and cancer-specific survival (CSS) of the two groups were compared and the independent factors that were associated with the two study endpoints were identified by multivariable regression analysis.

resultsOf the 1331 HCC patients enrolled in this study, 363 (27.27%) were elderly, while 968 (72.73%) were not. After PSM, 334 matched samples were obtained. In the propensity score matching (PSM) cohort, a higher rate of major morbidity was found in elderly patients (P = 0.040) but the CSS was similar in the two groups (P = 0.087). Multivariate analysis revealed that elderly age was not an independent risk factor associated with high rates of major morbidity (P = 0.117) or poor CSS (P = 0.873). The 1-, 3- and 5-year CSS rates in the elderly and non-elderly groups were 91.0% versus 86.2%, 71.3% versus 68.8% and 55.9% versus 58.0%, respectively. Preoperative alpha fetoprotein (AFP) level, Child‒Pugh grade, intraoperative blood transfusion, extended hemi hepatectomy, and tumour diameter could affect the postoperative major morbidity and preoperative AFP level, cirrhosis, Child‒Pugh grade, macrovascular invasion, microvascular invasion (MVI), satellite nodules, and tumor diameter were independently and significantly associated with CSS.

conclusionAge itself had no significant effect on the prognosis of elderly patients with HCC after hepatectomy. Hepatectomy can be safely performed in elderly patients after cautious perioperative management.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAgedalpha-FetoproteinsHepatectomyHumansMiddle AgedNeoplasm Recurrence, LocalPrognosisPropensity ScoreRetrospective Studiesalpha-FetoproteinsCancer-specific survivalElderly patientsHepatectomyHepatocellular carcinomaPrognosisPropensity score matching

Identifiers

PMID37875843
PMCPMC10594915
OpenAlexW4387905699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.